UK markets close in 3 hours 1 minute

Raphael Pharmaceutical Inc. (RAPH)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
1.54000.0000 (0.00%)
At close: 11:00AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
834
569
1,178
776
461
Selling general and administrative
727
703
2,139
853
245
Total operating expenses
1,561
1,272
3,317
1,629
706
Operating income or loss
-1,561
-1,272
-3,317
-1,629
-706
Total other income/expenses net
-
-9
-38
-
-
Income before tax
-1,570
-1,284
-3,358
-1,624
-718
Income from continuing operations
-1,570
-1,284
-3,358
-1,624
-718
Net income
-1,570
-1,284
-3,358
-1,624
-718
Net income available to common shareholders
-1,570
-1,284
-3,358
-1,624
-718
Basic EPS
-0.17
-
-0.23
-0.10
-0.05
Diluted EPS
-0.17
-
-0.23
-0.10
-0.05
Basic average shares
15,378
-
14,342
15,484
15,484
Diluted average shares
18,102
-
14,342
15,484
15,484